Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
about
Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
description
clinical trial
@en
klinisch onderzoek
@nl
name
Double-Blind Placebo Controlle ...... ausal Women With Schizophrenia
@en
type
label
Double-Blind Placebo Controlle ...... ausal Women With Schizophrenia
@en
prefLabel
Double-Blind Placebo Controlle ...... ausal Women With Schizophrenia
@en
P1476
Double-Blind Placebo Controlle ...... ausal Women With Schizophrenia
@en
P1813
DAAMSEL
@en
P3098
NCT01338298
P4844
P580
2011-01-01T00:00:00Z
P582
2016-12-01T00:00:00Z